[1] |
WANG Haodi, DENG Zhengming, WANG Gang, JIANG Zhiwei.
Disease burden in colorectal cancer attributed to fasting hyperglycemia in china from 1990 to 2021 and projections of future trends
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 61-67.
|
[2] |
CAO Le, MA Minmin, LI Wenmin, SHUI Mingming, JIANG Cheng.
Trend of mortality and disease burden of gastric cancer in China,2004—2021
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 68-73.
|
[3] |
WU Jialu, GE Xia, CHEN Wenming, YANG Guangzhong.
Current status and progress of CAR-T cell therapy in multiple myeloma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 525-531.
|
[4] |
WANG Huijuan, CHEN Wenming, GENG Chuanying, YANG Guangzhong .
Clinical characteristics of patients with relapsed/refractory multiple myeloma after CAR-T cell therapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 549-553.
|
[5] |
LYU Liwei, CONG Jia, WU Yiping, WANG Liang .
BCMA CAR-T cell therapy for relapsed/refractory plasmablastic lymphoma: case report and clinical implication
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 562-565.
|
[6] |
HE Ying, LI Mengjiao, CEN Yali, DOU Baitao, SHU Rou, LI Yanling, YAO Hao, FAN Fangyi.
CD19 CAR T-cell therapy: a case of refractory primary central nervous system diffuse large B-cell lymphoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 571-576.
|
[7] |
ZHAO Wensi, KE Shaobo, CHEN Jiamei, WU Yong, ZHANG Caiyutian, CHEN Yongshun.
Efficacy and safety of Fruquintinib combined with immune checkpoint inhibitors in later-line treatment of patients with microsatellite stable metastatic colorectal cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 598-605.
|
[8] |
ZHOU Da, WANG Mingyue, LI Zhe, HE Qing, CEN Hong.
Single-center clinical experience of daratumumab combined with bendamustine in the treatment of multiple myeloma patients with secondary extramedullary disease
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 412-416.
|
[9] |
ZHANG Tianyang, XIAO Wen, XIN Zhenjiang, XIE Junqing.
Analysis of screening results of early diagnosis and treatment program for colorectal cancer in rural areas Fengtai district,Beijing,2015—2022
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 447-453.
|
[10] |
ZUO Juntao, LI Jiaqi, XU Yao, CAI Lina, ZHENG Hengyu, SUN Ting, YE Xianghong.
Summary of the best evidence for perioperative nutritional management in patients with colorectal cancer by the concept of enhanced recovery
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 339-345.
|
[11] |
LI Ting, LI Qian, LI Yongqiang, LIAO Xiaoli.
Analysis of prognostic factors for patients with mismatch repair?proficient advanced colorectal cancer treated by immunotherapy combined with targeted therapy and its prediction nomogram construction
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 215-222.
|
[12] |
ZHU Lin, LU Ning, YANG Lin, WEN Hua, CUI Manli, ZHANG Mingxin.
The clinical value of inflammatory burden index in the diagnosis and prognosis of colorectal cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 543-548.
|
[13] |
LI Wei, LIU Ligang, YANG Junquan, LIU Chun, ZHANG Zhixue, GAO Fuchun, ZHANG Caixia, LIU Shuhong, LI Xinyu.
Analysis of the risk factors of anastomotic leakage after total laparoscopic transrectal specimen extraction surgery (NOSES Ⅳ) for colorectal cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 564-569.
|
[14] |
HUANG Chuntao, WEN Tianbin, LYU Sihui, LIANG Jinlan, WANG Qi.
Construction and validation of a prognostic model for cervical cancer based on tumor immune cycle-related genes
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(4): 398-405.
|
[15] |
HUANG Yu, ZHOU Xianguo, LI Xueyu, WEI Liuting, CAO Ji, RONG Minhua.
Effect of kinesin family member 23 on the proliferation and migration of colorectal cancer cells and its mechanism
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(6): 611-616.
|